Abstract
Leukocyte migration is a crucial component of defense against many infections and in the pathogenesis of multiple inflammatory disorders. Therefore, the elucidation of the mechanisms responsible for leukocyte recruitment is critical for the development of novel therapeutic approaches for these conditions. Among the molecules implicated in regulating leukocyte trafficking are the chemokines, low-molecular-weight secreted molecules that interact with G-protein-coupled receptors. Evidence supporting an important role for chemokines in leukocyte migration derives from studies employing (1) in vitro chemotaxis assays (1–4), (2) in vivo chemotaxis assays involving administration of exogenous recombinant mediators into a body cavity (5), (3) animal models of disease (6–10), and (4) transgenic models (11). Although critical to our understanding of these processes, both in vitro and in vivo chemotaxis assays are limited because they do not fully reproduce the complex environment of healthy or diseased tissues. On the other hand, the myriad perturbations in the biochemical and physical microenvironment of diseased tissue, including the expression of multiple mediators, changes in the characteristics of resident cells, and the influx of inflammatory cells, make it difficult to discern the role of a single mediator. In this context, studies on genetically engineered mice are uniquely positioned to examine the biology of both ligands and receptors in the environment of the relevant tissue without the confounding influence of coexisting disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baggiolini, M., Walz, A., and Kunkel, S. L. (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84, 1045–1049.
Richardson, M. D. and Patel, M. (1995) Stimulation of neutrophil phagocytosis of Aspergillus fumigatus conidia by interleukin-8 and N-formylmethionyl-leucylphenylalanine. J. Med. Vet. Mycol. 33, 99–104.
Thelen, M., Peveri, P., Kernen, P., von Tscharner, V., Walz, A., and Baggiolini, M. (1988) Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J. 2, 2702–2706.
Wolpe, S. D., Sherry, B., Juers, D., Davatelis, G., Yurt, R. W., and Cerami, A. (1989) Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA 86, 612–616.
Bozic, C. R., Kolakowski, L. F. Jr., Gerard, N. P., et al. (1995) Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154, 6048–6057.
Broaddus, V. C., Boylan, A. M., Hoeffel, J. M., et al. (1994) Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J. Immunol. 152, 2960–2967.
Greenberger, M. J., Strieter, R. M., Kunkel, S. L., et al. (1996) Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173, 159–165.
Huang, S., Paulauskis, J. D., Godleski, J. J., and Kobzik, L. (1992) Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am. J. Pathol. 141, 981–988.
Kooguchi, K., Hashimoto, S., Kobayashi, A., et al. (1998) Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 66, 3164–3169.
Sekido, N., Mukaida, N., Harada, A., Nakanishi, I., Watanabe, Y., and Matsushima, K. (1993) Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365, 654–657.
Lira, S. A. (1999) Lessons from gene modified mice. Forum (Genova) 9, 286–298.
Boring, L., Gosling, J., Chensue, S. W., et al. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100, 2552–2561.
Boring, L., Gosling, J., Cleary, M., and Charo, I. F. (1998) Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894–897.
Cook, D. N., Prosser, D. M., Forster, R., et al. (2000) CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12, 495–503.
Forster, R., Mattis, A. E., Kremmer, E., Wolf, E., Brem, G., and Lipp, M. (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037–1047.
Forster, R., Schubel, A., Breitfeld, D., et al. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23–33.
Gao, J. L., Wynn, T. A., Chang, Y., et al. (1997) Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185, 1959–1968.
Gosling, J., Slaymaker, S., Gu, L., et al. (1999) MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103, 773–778.
Gu, L., Okada, Y., Clinton, S. K., et al. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275–281.
Fuentes, M. E., Durham, S. K., Swerdel, M. R., et al. (1995) Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J. Immunol. 155, 5769–5776.
Grewal, I. S., Rutledge, B. J., Fiorillo, J. A., et al. (1997) Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J. Immunol. 159, 401–408.
Gunn, M. D., Nelken, N. A., Liao, X., and Williams, L. T. (1997) Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J. Immunol. 158, 376–383.
Kolattukudy, P. E., Quach, T., Bergese, S., et al. (1998) Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am. J. Pathol. 152, 101–111.
Lira, S. A., Zalamea, P., Heinrich, J. N., et al. (1994) Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J. Exp. Med. 180, 2039–2048.
Tani, M., Fuentes, M. E., Peterson, J. W., et al. (1996) Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J. Clin. Invest. 98, 529–539.
Tanaka, Y., Imai, T., Baba, M., et al. (1999) Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur. J. Immunol. 29, 633–642.
D’Ambrosio, D., Iellem, A., Bonecchi, R., et al. (1998) Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 161, 5111–5115.
Gossen, M., Bonin, A. L., and Bujard, H. (1993) Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem. Sci. 18, 471–475.
Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547–5551.
Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766–1769.
Furth, P. A., St. Onge, L., Boger, H., et al. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302–9306.
Kistner, A., Gossen, M., Zimmermann, F., et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 10,933–10,938.
Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., and Hillen, W. (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA 97, 7963–7968.
Oquendo, P., Alberta, J., Wen, D. Z., Graycar, J. L., Derynck, R., and Stiles, C. D. (1989) The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet alpha-granule proteins. J. Biol. Chem. 264, 4133–4137.
Ryseck, R. P., MacDonald-Bravo, H., Mattei, M. G., and Bravo, R. (1989) Cloning and sequence of a secretory protein induced by growth factors in mouse fibroblasts. Exp. Cell Res. 180, 266–275.
Wiekowski, M. T., Chen, S. C., Zalamea, P., et al. (2001) Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J. Immunol. 167, 7102–7110.
Zullo, J. N., Cochran, B. H., Huang, A. S., and Stiles, C. D. (1985) Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 43, 793–800.
Suzuki, H., Prado, G. N., Wilkinson, N., and Navarro, J. (1994) The N terminus of interleukin-8 (IL-8) receptor confers high affinity binding to human IL-8. J. Biol. Chem. 269, 18,263–18,268.
Lee, J., Cacalano, G., Camerato, T., Toy, K., Moore, M. W., and Wood, W. I. (1995) Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155, 2158–2164.
Cochran, B. H., Reffel, A. C., and Stiles, C. D. (1983) Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33, 939–947.
Harada, A., Kuno, K., Nomura, H., Mukaida, N., Murakami, S., and Matsushima, K. (1994) Cloning of a cDNA encoding a mouse homolog of the interleukin-8 receptor. Gene 142, 297–300.
Bozic, C. R., Gerard, N. P., von Uexkull-Guldenband, C., et al. (1994) The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J. Biol. Chem. 269, 29,355–29,358.
Lira, S. A., Fuentes, M. E., Strieter, R. M., and Durham, S. K. (1997) Transgenic methods to study chemokine function in lung and central nervous system. Methods Enzymol. 287, 304–318.
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., and Nishimune, Y. (1997) “Green mice” as a source of ubiquitous green cells. FEBS Lett. 407, 313–319.
Manfra, D. J., Chen, S. C., Yang, T. Y., et al. (2001) Leukocytes expressing green fluorescent protein as novel reagents for adoptive cell transfer and bone marrow transplantation studies. Am. J. Pathol. 158, 41–47.
Kalmar, J. R. and Van Dyke, T. E. (1994) Effect of bacterial products on neutrophil chemotaxis. Methods Enzymol. 236, 58–87.
Van Zee, K. J., Fischer, E., Hawes, A. S., et al. (1992) Effects of intravenous IL-8 administration in nonhuman primates. J. Immunol. 148, 1746–1752.
Hechtman, D. H., Cybulsky, M. I., Fuchs, H. J., Baker, J. B., and Gimbrone, M. A. Jr. (1991) Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 147, 883–892.
Blackwell, T. S., Lancaster, L. H., Blackwell, T. R., Venkatakrishnan, A., and Christman, J. (1999) Chemotactic gradients predict neutrophilic alveolitis in endotoxin-treated rats. Am. J. Respir. Crit. Care Med. 159, 1644–1652.
Simonet, W., Hughes, T., Nguyen, H., Trebasky, L., Danilenko, D., and Medlock, E. (1994) Long-term impaired neutrophil migration in mice overexpressing human interleuklin-8. J. Clin. Invest. 94, 1310–1319.
Rutledge, B. J., Rayburn, H., Rosenberg, R., et al. (1995) High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J. Immunol. 155, 4838–4843.
Cacalano, G., Lee, J., Kikly, K., et al. (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265, 682–684.
McColl, S. R. and Clark-Lewis, I. (1999) Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J. Immunol. 163, 2829–2835.
Lukacs, N. W., Strieter, R. M., Chensue, S. W., and Kunkel, S. L. (1996) Activation and regulation of chemokines in allergic airway inflammation. J. Leukocyte Biol. 59, 13–17.
Standiford, T. J. (1997) Cytokines and pulmonary host defenses. Curr. Opin. Pulm. Med. 3, 81–88.
Griffiths-Johnson, D. A., Collins, P. D., Jose, P. J., and Williams, T. J. (1997) Animal models of asthma: role of chemokines. Methods Enzymol. 288, 241–266.
Mehrad, B., Wiekowski, B. E., Morrison, S. C., et al. (2002) Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. Am. J. Respir. Crit. Care Med. 166, 1263–1268.
Stripp, B. R., Sawaya, P. L., Luse, D. S., et al. (1992) Cis-acting elements that confer lung epithelial cell expression of the CC10 gene. J. Biol. Chem. 267, 14,703–14,712.
Sawaya, P. L., Stripp, B. R., Whitsett, J. A., and Luse, D. S. (1993) The lung-specific CC10 gene is regulated by transcription factors from the AP-1, octamer, and hepatocyte nuclear factor 3 families. Mol. Cell. Biol. 13, 3860–3871.
Frevert, C. W., Huang, S., Danaee, H., Paulauskis, J. D., and Kobzik, L. (1995) Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J. Immunol. 154, 335–344.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Lira, S.A. et al. (2004). Conditional Transgenic Models to Study Chemokine Biology. In: D’Ambrosio, D., Sinigaglia, F. (eds) Cell Migration in Inflammation and Immunity. Methods in Molecular Biology™, vol 239. Humana Press. https://doi.org/10.1385/1-59259-435-2:105
Download citation
DOI: https://doi.org/10.1385/1-59259-435-2:105
Publisher Name: Humana Press
Print ISBN: 978-1-58829-102-8
Online ISBN: 978-1-59259-435-1
eBook Packages: Springer Protocols